SEC Form D · filed April 28, 2021
Clover Biopharmaceuticals, Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Peng Liang · Chengdu, IsraelExec · Director · PromoterXiaodong Wang · Yarrow Point, WADirectorJoshua Liang · Chengdu, IsraelExec · DirectorWilliam W. Cagney · Luxembourg, LuxembourgExec · DirectorChristophe W. Lentschat · Luxembourg, LuxembourgDirectorToru Ihara · Kanagawa, M0Exec · Director · PromoterGuangyu Xu · Beijing, IsraelDirectorDong Lyu · Beijing, IsraelDirectorTing Xiao · Hong Kong, Hong KongDirectorJ. T. David · Amarillo, TXDirectorKeisha M. Dawson · Amarillo, TXExec · DirectorFaye P. Mcgrath · Berkeley, CAExec · Director · PromoterGuangyu Xu · Beijing, IsraelDirectorDong Lyu · Beijing, IsraelDirectorTing Xiao · Hong Kong, Hong KongDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗